Skip to main content
Chandan Mehta, MD, Neurology, Detroit, MI

ChandanBharatMehtaMD

Neurology Detroit, MI

Neurocritical Care

Neurointensivist, Neurologist

Dr. Mehta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mehta's full profile

Already have an account?

  • Office

    2799 W Grand Blvd
    # Henry
    Detroit, MI 48202
    Phone+1 313-916-1601

Education & Training

  • Henry Ford Hospital/Wayne State University
    Henry Ford Hospital/Wayne State UniversityFellowship, Neurocritical Care, 2014 - 2016
  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalChief Residency, Neurology, 2013 - 2014
  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Neurology, 2011 - 2014
  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalInternship, Transitional Year, 2010 - 2011
  • Ross University School of Medicine
    Ross University School of MedicineClass of 2009

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2014 - 2027
  • American Board of Psychiatry and Neurology Neurology
  • United Council for Neurological SubspecialtiesNeurocritical Care Board Certification

Awards, Honors, & Recognition

  • Resident Scholarship recipient American Academy of Neurology Annual Meeting, 2014
  • Internal Medicine Resident of the Month Henry Ford Hospital, 2010

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Opsoclonus as a Manifestation of Hashimoto’s Encephalopathy  
    Salazar R, Mehta C, Zaher N, Miller D, Journal of Clinical Neuroscience, 10/1/2012
  • Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease (Acknowledgement)  
    Conley A, Manjila S, Guan H, Guthikonda M, Kupsky WJ, Mittal S, Neuropathology, 12/1/2010
  • Dendrimer-based nanomedicine: engineered nanodevice synthesis, characterization, and biological testing  
    Majoros IJ, Thommey TP, Candido KA, IslamMT, Woehler S, Mehta CB, Kotlyar A, Cao Z, Kukowska-Latallo JF, Baker JR, Biokemia, 1/1/2007
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Multidisciplinary Management of Cerebral Edema Associated with Fulminant Hepatic Encephalopathy in a Neurosciences Intensive Care Unit.
    Varelas PN, Mehta C, Ramadan AR, Hawley M, Abdelhak T and Rehman M, Neurology, 1/1/2014
  • Rapid Bilateral Sensorineural Hearing Loss in a Patient with Creuztfeldt-Jacob Disease.
    Ramadan AR, Patel K, Mehta C, Maldonado N, Mitsias PM, Neurology, 1/1/2013
  • Comparative Analysis Of The Treatment Options For Cerebral Venous Sinus Thrombosis In The United States.
    Patel K, Mehta C, Maldonado N, Kaskar O, Schultz L, Abdelhak T, Varelas V, Neurology, 1/1/2013
  • Join now to see all

Press Mentions

  • Recommended Reversal Time of Vitamin K Antagonists Identified for ICH
    Recommended Reversal Time of Vitamin K Antagonists Identified for ICHApril 17th, 2016
  • Recommended Reversal Time of Vitamin K Antagonists Identified for ICH
    Recommended Reversal Time of Vitamin K Antagonists Identified for ICHApril 17th, 2016

Professional Memberships